Cargando…
Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience
OBJECTIVES: To compare the perioperative and oncological outcomes of robotic-assisted tumor enucleation (RATE) and robotic-assisted partial nephrectomy (RAPN) in the treatment of intermediate and high complexity renal cell carcinoma (RCC). METHODS: We retrospectively collected the data of 359 patien...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249187/ https://www.ncbi.nlm.nih.gov/pubmed/37287019 http://dx.doi.org/10.1186/s12957-023-03060-3 |
_version_ | 1785055507159973888 |
---|---|
author | Lei, Kunyang Wang, Xu Yang, Zhongsheng Zhong, Yuming Liu, Yifu Sun, Ting |
author_facet | Lei, Kunyang Wang, Xu Yang, Zhongsheng Zhong, Yuming Liu, Yifu Sun, Ting |
author_sort | Lei, Kunyang |
collection | PubMed |
description | OBJECTIVES: To compare the perioperative and oncological outcomes of robotic-assisted tumor enucleation (RATE) and robotic-assisted partial nephrectomy (RAPN) in the treatment of intermediate and high complexity renal cell carcinoma (RCC). METHODS: We retrospectively collected the data of 359 patients with intermediate and high complexity RCC who underwent RATE and RAPN. The perioperative, oncological, and pathological outcomes of the two groups were compared, and univariate and multivariate analyses were used to evaluate the risk factors for warm ischemia time (WIT) > 25 min. RESULTS: Compared with RAPN group, patients in RATE group had shorter operative time (P < 0.001), shorter WIT (P < 0.001), and less estimated blood loss (EBL) (P < 0.001). The decrease rate of estimated glomerular filtration rate (eGFR) in RATE group was better than that in RAPN group (P < 0.001). Multivariable analysis showed that RAPN and higher PADUA score were independent risk factors for WIT > 25 min (both P < 0.001). The rate of positive surgical margin was similar between the two groups, but the local recurrence rate of the RATE group was higher than that of the RAPN group (P = 0.027). CONCLUSIONS: RATE and RAPN have similar oncological outcomes for the treatment of intermediate and high complexity RCC. In addition, RATE was superior to RAPN in perioperative outcomes. |
format | Online Article Text |
id | pubmed-10249187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102491872023-06-09 Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience Lei, Kunyang Wang, Xu Yang, Zhongsheng Zhong, Yuming Liu, Yifu Sun, Ting World J Surg Oncol Research OBJECTIVES: To compare the perioperative and oncological outcomes of robotic-assisted tumor enucleation (RATE) and robotic-assisted partial nephrectomy (RAPN) in the treatment of intermediate and high complexity renal cell carcinoma (RCC). METHODS: We retrospectively collected the data of 359 patients with intermediate and high complexity RCC who underwent RATE and RAPN. The perioperative, oncological, and pathological outcomes of the two groups were compared, and univariate and multivariate analyses were used to evaluate the risk factors for warm ischemia time (WIT) > 25 min. RESULTS: Compared with RAPN group, patients in RATE group had shorter operative time (P < 0.001), shorter WIT (P < 0.001), and less estimated blood loss (EBL) (P < 0.001). The decrease rate of estimated glomerular filtration rate (eGFR) in RATE group was better than that in RAPN group (P < 0.001). Multivariable analysis showed that RAPN and higher PADUA score were independent risk factors for WIT > 25 min (both P < 0.001). The rate of positive surgical margin was similar between the two groups, but the local recurrence rate of the RATE group was higher than that of the RAPN group (P = 0.027). CONCLUSIONS: RATE and RAPN have similar oncological outcomes for the treatment of intermediate and high complexity RCC. In addition, RATE was superior to RAPN in perioperative outcomes. BioMed Central 2023-06-08 /pmc/articles/PMC10249187/ /pubmed/37287019 http://dx.doi.org/10.1186/s12957-023-03060-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lei, Kunyang Wang, Xu Yang, Zhongsheng Zhong, Yuming Liu, Yifu Sun, Ting Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience |
title | Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience |
title_full | Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience |
title_fullStr | Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience |
title_full_unstemmed | Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience |
title_short | Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience |
title_sort | robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249187/ https://www.ncbi.nlm.nih.gov/pubmed/37287019 http://dx.doi.org/10.1186/s12957-023-03060-3 |
work_keys_str_mv | AT leikunyang roboticassistedtumorenucleationversusroboticassistedpartialnephrectomyforintermediateandhighcomplexityrenalcellcarcinomaasingleinstitutionexperience AT wangxu roboticassistedtumorenucleationversusroboticassistedpartialnephrectomyforintermediateandhighcomplexityrenalcellcarcinomaasingleinstitutionexperience AT yangzhongsheng roboticassistedtumorenucleationversusroboticassistedpartialnephrectomyforintermediateandhighcomplexityrenalcellcarcinomaasingleinstitutionexperience AT zhongyuming roboticassistedtumorenucleationversusroboticassistedpartialnephrectomyforintermediateandhighcomplexityrenalcellcarcinomaasingleinstitutionexperience AT liuyifu roboticassistedtumorenucleationversusroboticassistedpartialnephrectomyforintermediateandhighcomplexityrenalcellcarcinomaasingleinstitutionexperience AT sunting roboticassistedtumorenucleationversusroboticassistedpartialnephrectomyforintermediateandhighcomplexityrenalcellcarcinomaasingleinstitutionexperience |